Navigating Metabolic Challenges in Ovarian Cancer: Insights and Innovations in Drug Repurposing
ABSTRACT Background Ovarian cancer (OC) is the most lethal gynecological malignancy and a major global health concern, often diagnosed at advanced stages with poor survival rates. Despite advancements in treatment, resistance to standard chemotherapy remains a critical challenge with limited treatme...
Saved in:
| Main Authors: | Sara Mikhael, Georges Daoud |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70681 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance
by: Lanyue Zhang, et al.
Published: (2025-03-01) -
Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
by: Liu Jia, et al.
Published: (2025-05-01) -
Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer
by: Jing Li, et al.
Published: (2025-07-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01) -
NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK/ERK/PD-L1 pathway
by: Yingying Qi, et al.
Published: (2025-04-01)